Lim Jihye, Kim Sung-Eun, Jo Ae Jeong, Kim Jung Hee, Han Seul Ki, Kim Tae Hyung, Yim Hyung Joon, Jung Young Kul, Song Do Seon, Yoon Eileen L, Kim Hee Yeon, Kang Seong Hee, Chang Young, Yoo Jeong-Ju, Lee Sung Won, Park Jung Gil, Park Ji Won, Jeong Soung Won, Jin Young Joo, Kim Hyoung Su, Suk Ki Tae, Kim Moon Young, Kim Sang Gyune, Kim Won, Jang Jae Young, Yang Jin Mo, Kim Dong Joon
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, 24252, Republic of Korea.
Hepatol Int. 2024 Oct;18(5):1579-1588. doi: 10.1007/s12072-024-10710-5. Epub 2024 Jul 17.
Previous studies have investigated the influence of diabetes on alcoholic liver cirrhosis patients, leaving its impact unclear. Thus, we conducted a study to reveal the association of diabetes and clinical outcomes of such patients.
We prospectively collected data from multicenter pertaining to 965 patients diagnosed with alcoholic liver cirrhosis, all of whom were admitted due to acute decompensation between 2015 and 2019. Risk of major precipitating factors and incidences of death or liver transplantation in patients with and without diabetes was comparatively assessed. Propensity score (PS) matching was performed at a 1:2 ratio for accurate comparisons.
The mean age was 53.4 years, and 81.0% of the patients were male. Diabetes was prevalent in 23.6% of the cohort and was positively correlated with hepatic encephalopathy and upper gastrointestinal bleeding, although not statistically significant. During a median follow-up of 903.5 person-years (PYs), 64 patients with and 171 without diabetes died or underwent liver transplantation, with annual incidence of 33.6/100 PYs and 24.0/100 PYs, respectively. In the PS-matched cohort, the incidence of death or liver transplantation was 36.8/100 PYs and 18.6/100 PYs in the diabetes and matched control group, respectively. After adjusting for various factors, coexisting diabetes significantly heightened the risk of death or liver transplantation in the short and long term, in addition to prolonged prothrombin time, low serum albumin, elevated total bilirubin and creatinine, and decreased serum sodium levels.
Diabetes increases the risk of death or liver transplantation in patients with alcoholic liver cirrhosis.
既往研究探讨了糖尿病对酒精性肝硬化患者的影响,但其影响尚不清楚。因此,我们开展了一项研究以揭示糖尿病与此类患者临床结局之间的关联。
我们前瞻性地收集了多中心965例诊断为酒精性肝硬化患者的数据,所有患者均因2015年至2019年间急性失代偿入院。比较评估了有糖尿病和无糖尿病患者的主要诱发因素风险以及死亡或肝移植发生率。为进行准确比较,以1:2的比例进行倾向评分(PS)匹配。
平均年龄为53.4岁,81.0%的患者为男性。23.6%的队列患者患有糖尿病,糖尿病与肝性脑病和上消化道出血呈正相关,尽管无统计学意义。在中位随访903.5人年(PYs)期间,64例糖尿病患者和171例非糖尿病患者死亡或接受肝移植,年发生率分别为33.6/100 PYs和24.0/100 PYs。在PS匹配队列中,糖尿病组和匹配对照组的死亡或肝移植发生率分别为36.8/100 PYs和18.6/100 PYs。在调整各种因素后,并存糖尿病除了会延长凝血酶原时间、降低血清白蛋白、升高总胆红素和肌酐以及降低血清钠水平外,还会在短期和长期显著增加死亡或肝移植风险。
糖尿病增加了酒精性肝硬化患者的死亡或肝移植风险。